companydata.dkcompanydata.dk

NORDIC BIOTECH GENERAL PARTNER ApS: Financial statements 2013

CVR: 26270367

Source: annual report 2013, Danish Business Authority

01/01/2013 – 31/12/2013

NORDIC BIOTECH GENERAL PARTNER ApS (CVR 26270367) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK 21,988 and a net result of DKK 16,323 compared with DKK 15,398 the year before. That is an increase of 7.1% compared with the year before. Equity in the 2013 report amounted to DKK 241,856. The solvency ratio was 92.7%.

Gross Profit
DKK 21,988
Profit/Loss
DKK 16,323
Equity
DKK 241,856
Total Assets
DKK 260,978

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2013-22K16K242K-
2012-21K15K226K-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2013

NORDIC BIOTECH GENERAL PARTNER ApS: The 2012 annual report is outMay 27, 2013

NORDIC BIOTECH GENERAL PARTNER ApS has published its annual report for 2012. Gross profit came to DKK 20,526, and the net result was DKK 15,398.

About NORDIC BIOTECH GENERAL PARTNER ApS

NORDIC BIOTECH GENERAL PARTNER ApS is a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company is in liquidation. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jakob Mosegaard Larsen. The company is owned by TECH GROWTH INVEST ApS and C. HANSEN INVEST ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 163,699 and a net result of DKK 178,169 compared with DKK 67,346 the year before. Equity in the 2025 report amounted to DKK 1,214,065.

Source: annual report 2025, Danish Business Authority